九典制药：关于受让取得药物临床试验批准通知书的公告

Core Insights - The company announced the acquisition of all developed results and corresponding intellectual property of JIJ02 gel from Chengdu Ped Bio-pharmaceutical Co., Ltd. for 90 million yuan [1] - The company has completed the transfer procedures for the clinical approval documents related to the product [1] Group 1 - The acquisition amount for the JIJ02 gel is 90 million yuan [1] - The original name of the gel was "PD-DP-008 gel" [1] - The company signed a technology transfer contract with Chengdu Ped [1]